Abstract
Time delay to cancer treatment places increased anxiety upon the patient and oncology team. These potential delays have prevented women from undergoing fertility preservation treatment. Most recently, the movement toward neoadjuvant therapy for breast cancer has increased the potential for delay. Alternative ovarian stimulation strategies have been implemented to minimize delays to cancer treatment. In the study, we sought to determine whether random start stimulation allows for minimal delays to neoadjuvant chemotherapy start in breast cancer patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
